The LICQual Level 6 Diploma in Pharmaceutical Biotechnology (D Pharmaceutical Biotechnology) is an advanced qualification tailored for professionals seeking to progress their careers in the pharmaceutical and biotechnology industries. This diploma is not intended for fresh candidates; it is specifically designed for experienced learners who wish to build upon their existing expertise, strengthen their professional competencies, and expand their Continuing Professional Development (CPD).
Pharmaceutical biotechnology continues to play a pivotal role in shaping the future of global healthcare. From biopharmaceuticals and genetic engineering to innovative drug development and large-scale manufacturing, this diploma equips learners with in-depth knowledge and practical understanding of the latest advancements and challenges within the industry. It prepares professionals to take on higher-level responsibilities, ensuring they can contribute to innovation, compliance, and leadership within their organisations.
Centres delivering the Level 6 Diploma in Pharmaceutical Biotechnology must demonstrate a strong commitment to academic and professional excellence. This includes employing qualified and competent staff with proven expertise in pharmaceutical biotechnology, as well as ensuring access to laboratories, study materials, and specialist resources necessary to support advanced learning. Such requirements are essential to maintaining the highest standards of training and ensuring that every learner has the opportunity to achieve success.
By undertaking this diploma, learners gain the strategic skills, scientific knowledge, and regulatory awareness needed to thrive in the evolving biotechnology landscape. It offers a clear pathway for career advancement, professional recognition, and long-term success in the pharmaceutical biotechnology sector.
Course Overview
Qualification Title
LICQual Level 6 Diploma in Pharmaceutical Biotechnology (D Pharmaceutical Biotechnology)
Total Units
6
Total Credits
120
GLH
480
Qualification #
LICQ2201209
Qualification Specification
To enroll in the LICQual Level 6 Diploma in Pharmaceutical Biotechnology (D Pharmaceutical Biotechnology), applicants must meet the following criteria:
Qualification# |
Unit Title 19361_bed6cc-f5> |
Credits 19361_954095-13> |
GLH 19361_08492c-6e> |
---|---|---|---|
LICQ2201209-1 19361_eb302b-49> |
Advanced Principles of Pharmaceutical Biotechnology 19361_779439-70> |
20 19361_7e9c10-0f> |
80 19361_b048f7-15> |
LICQ2201209-2 19361_51032f-ca> |
Biopharmaceutical Product Development and Commercialization 19361_353f4e-18> |
20 19361_315955-d8> |
80 19361_c54028-6b> |
LICQ2201209-3 19361_b64951-79> |
Regulatory Affairs, Governance, and Compliance 19361_4e4de0-a5> |
20 19361_3311a3-08> |
80 19361_7b49ad-03> |
LICQ2201209-4 19361_ff55b4-47> |
Advanced Quality Assurance and Quality Control Systems 19361_059651-b6> |
20 19361_fb2ae4-19> |
80 19361_29f41b-21> |
LICQ2201209-5 19361_1f59d2-07> |
Bioprocess Engineering and Industrial Applications 19361_f4a4dd-3d> |
20 19361_cecd4a-79> |
80 19361_e6547f-fb> |
LICQ2201209-6 19361_26ed24-2b> |
Research, Innovation, and Strategic Leadership in Biotechnology 19361_ff32a2-a5> |
20 19361_41d67b-04> |
80 19361_3ac19f-3f> |
By the end of this course, learners will be able to:
Unit 1: Advanced Principles of Pharmaceutical Biotechnology
By the end of this unit, learners will be able to:
- Critically evaluate advanced principles of biotechnology and their pharmaceutical applications
- Apply molecular biology, genetic engineering, and bioinformatics tools in drug discovery and development
- Analyse the contribution of biotechnology to innovative therapeutic solutions
Unit 2: Biopharmaceutical Product Development and Commercialisation
By the end of this unit, learners will be able to:
- Demonstrate knowledge of advanced drug formulation and large-scale biopharmaceutical production processes
- Evaluate strategies for product lifecycle management from research through to market release
- Assess global opportunities and challenges in the commercialisation of biopharmaceutical products
Unit 3: Regulatory Affairs, Governance, and Compliance
By the end of this unit, learners will be able to:
- Interpret and apply international regulatory standards including GMP, GLP, GCP, and ICH guidelines
- Analyse the ethical, legal, and governance considerations in pharmaceutical biotechnology
- Prepare and review regulatory documentation to support product approval and compliance
Unit 4: Advanced Quality Assurance and Quality Control Systems
By the end of this unit, learners will be able to:
- Design and implement comprehensive QA and QC systems for biotechnology-based pharmaceuticals
- Apply advanced analytical and validation methods to ensure product quality and safety
- Critically evaluate compliance strategies to meet global quality standards
Unit 5: Bioprocess Engineering and Industrial Applications
By the end of this unit, learners will be able to:
- Analyse advanced bioprocess engineering techniques used in large-scale manufacturing
- Evaluate fermentation, purification, and downstream processing methods in biotechnology production
- Apply principles of automation and optimisation to improve industrial bioprocess efficiency
Unit 6: Research, Innovation, and Strategic Leadership in Biotechnology
By the end of this unit, learners will be able to:
- Conduct applied research to evaluate and contribute to advancements in biotechnology
- Develop innovation strategies that support sustainable and personalised medicine development
- Demonstrate leadership and strategic decision-making skills in addressing global biotechnology challenges
The LICQual Level 6 Diploma in Pharmaceutical Biotechnology (D Pharmaceutical Biotechnology) is designed for experienced professionals who are already established in the pharmaceutical, biotechnology, or life sciences sectors and wish to advance their careers. This qualification is not suitable for fresh candidates; it is specifically tailored for learners who are ready to take on senior responsibilities, expand their expertise, and strengthen their Continuing Professional Development (CPD).
This course is ideal for:
- Pharmaceutical professionals aiming to progress into leadership or specialist roles in biotechnology and advanced drug development.
- Biotechnology researchers and scientists seeking to deepen their knowledge of product innovation, compliance, and industrial applications.
- Regulatory and quality assurance professionals who need to enhance their understanding of international standards such as GMP, GLP, GCP, and ICH guidelines.
- Production managers and bioprocess engineers looking to master advanced manufacturing, automation, and large-scale processing techniques.
- Healthcare and life sciences professionals who want to gain expertise in biopharmaceutical product development and global healthcare innovations.
- CPD-focused professionals committed to strengthening their career pathways and achieving recognition within the pharmaceutical biotechnology sector.
Enrolling in this diploma provides learners with advanced scientific knowledge, strategic leadership skills, and practical insights that enable them to thrive in the evolving biotechnology landscape and secure long-term professional success.
Centres delivering the LICQual Level 6 Diploma in Pharmaceutical Biotechnology (D Pharmaceutical Biotechnology) must meet strict requirements to ensure high-quality training, effective learner engagement, and internationally recognised academic standards. These requirements are essential for guaranteeing that learners benefit from advanced professional education and achieve successful outcomes.
- Qualified and Experienced Staff
Centres must employ trainers, assessors, and internal quality assurers with advanced academic qualifications and extensive industry experience in pharmaceutical biotechnology or related disciplines. Staff should also demonstrate ongoing professional development to ensure up-to-date knowledge. - Access to Advanced Learning Resources
Learners must be provided with access to high-quality study materials, reference texts, e-learning platforms, and industry publications. Centres are responsible for ensuring that resources remain current and aligned with global pharmaceutical biotechnology standards. - Specialised Laboratory and Technical Facilities
Adequate laboratories and specialist equipment must be available to support practical training in bioprocessing, quality control, drug development, and regulatory compliance. These facilities are vital for learners to apply theoretical knowledge in advanced real-world scenarios. - Robust Quality Assurance Systems
Centres must implement effective internal quality assurance policies, monitoring, and assessment procedures to maintain consistency, transparency, and compliance with international best practices. - Comprehensive Learner Support
Centres are required to provide tailored learner support, including academic mentoring, career guidance, and CPD planning. This ensures learners are supported throughout their qualification journey. - Commitment to Excellence
Centres must maintain the highest standards of professional training delivery, ensuring that every learner receives structured, reliable, and industry-relevant education.
By fulfilling these requirements, centres will be well-positioned to deliver a world-class learning experience and help learners excel in the Level 6 Diploma in Pharmaceutical Biotechnology.
Assessment and Verification
All units within this qualification are subject to internal assessment by the approved centre and external verification by LICQual. The qualification follows a criterion-referenced assessment approach, ensuring that learners meet all specified learning outcomes.
To achieve a ‘Pass’ in any unit, learners must provide valid, sufficient, and authentic evidence demonstrating their attainment of all learning outcomes and compliance with the prescribed assessment criteria. The Assessor is responsible for evaluating the evidence and determining whether the learner has successfully met the required standards.
Assessors must maintain a clear and comprehensive audit trail, documenting the basis for their assessment decisions to ensure transparency, consistency, and compliance with quality assurance requirements.